GSK’s (GSK) Buy Rating Reaffirmed at Shore Capital

Shore Capital reissued their buy rating on shares of GSK (LON:GSK) in a research note released on Thursday, MarketBeat Ratings reports.

Several other research firms have also weighed in on GSK. Jefferies Financial Group restated a buy rating and set a GBX 2,100 ($26.64) price objective on shares of GSK in a research report on Thursday. Barclays restated an equal weight rating and issued a GBX 1,725 ($21.88) price target on shares of GSK in a research report on Tuesday, May 7th. Citigroup reiterated a buy rating and set a GBX 2,100 ($26.64) price objective on shares of GSK in a research report on Monday. JPMorgan Chase & Co. restated an underweight rating on shares of GSK in a report on Tuesday, June 18th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a buy rating and set a GBX 1,950 ($24.74) target price on shares of GSK in a research report on Tuesday, June 18th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of Moderate Buy and an average price target of GBX 1,791.25 ($22.72).

GSK Trading Up 0.2 %

Shares of GSK stock opened at GBX 1,528.68 ($19.39) on Thursday. The business has a fifty day simple moving average of GBX 1,688.38 and a 200-day simple moving average of GBX 1,629.94. GSK has a fifty-two week low of GBX 1,302.60 ($16.52) and a fifty-two week high of GBX 1,823.50 ($23.13). The firm has a market cap of £62.37 billion, a price-to-earnings ratio of 1,400.00, a price-to-earnings-growth ratio of 1.19 and a beta of 0.27. The company has a quick ratio of 0.73, a current ratio of 0.87 and a debt-to-equity ratio of 134.34.

GSK Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, July 11th. Shareholders of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share. The ex-dividend date is Thursday, May 16th. This represents a yield of 0.9%. GSK’s dividend payout ratio (DPR) is presently 5,504.59%.

Insider Activity

In related news, insider Wendy Becker purchased 446 shares of the firm’s stock in a transaction that occurred on Thursday, June 20th. The stock was acquired at an average cost of GBX 1,614 ($20.47) per share, for a total transaction of £7,198.44 ($9,131.60). 1.60% of the stock is owned by corporate insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.